News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement
|Articles|December 1, 2012

Kawasaki disease

Some recent studies show the significant effects of Kawasaki disease on coronary arteries. Researchers all agree on the urgent need for early diagnosis and improved treatment therapies.

Advertisement

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Advertisement

Related Content

Advertisement
Phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years and older | Image Credit: © aboutnuylove - stock.adobe.com.

Phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years and older

ByMorgan Ebert, Managing Editor
January 23rd 2026
Accelerated aging linked to cognitive decline in young cancer survivors | Image Credit: urmc.rochester.edu.

Accelerated aging linked to cognitive decline in young cancer survivors

ByAnnaLynn M. Williams,Kevin Krull, PhD
January 23rd 2026
FDA clears first at-home test to detect RSV, flu, and COVID-19 in infants as young as 6 months

FDA clears first at-home test to detect RSV, flu, and COVID-19 in infants as young as 6 months

ByMorgan Ebert, Managing Editor
January 23rd 2026
Five youth suicide profiles identified to improve prevention efforts | Image Credit: © primipil - © primipil - stock.adobe.com.

Five youth suicide profiles identified to improve prevention efforts

ByCeleste Krewson, Assistant Editor
January 23rd 2026
Community water fluoridation not associated with adverse birth weight outcomes | Image Credit: © Dusan Petkovic - stock.adobe.com.

Community water fluoridation not associated with adverse birth weight outcomes

ByMorgan Ebert, Managing Editor
January 22nd 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management
Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

View more
Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management
Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

View more
Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

FDA clears first at-home test to detect RSV, flu, and COVID-19 in infants as young as 6 months

2

Themes identified for using GLP-1 RAs to manage obesity in food-insecure children

3

Phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years and older

4

Five youth suicide profiles identified to improve prevention efforts

5

Andrea Rivera-Sepulveda, MD, MSc, discusses asthma risk following HFNC use

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us